TCG Crossover GP II, LLC 13D and 13G filings for Astria Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 4:21 pm Sale | 2024-09-30 | 13G | Astria Therapeutics, Inc. ATXS | TCG Crossover GP II, LLC | 2,761,861 4.900% | -1,607,067 (-36.78%) | Filing |
| 2024-01-16 4:18 pm Purchase | 2024-01-05 | 13G | Astria Therapeutics, Inc. ATXS | TCG Crossover GP II, LLC | 4,368,928 9.900% | 4,368,928 (New Position) | Filing |